And

are now a part of the new and improved

search Created with Sketch.
search Created with Sketch.

Advertisement

Topic: Eczema

News | October 18, 2019

Lilly: New Data for Treatment of Complex Dermatological Conditions at EADV, Maui Derm NP+PA

New data for Eli Lilly and Company’s Taltz® (ixekizumab), Olumiant® (baricitinib) and mirikizumab have been presented at the 28th annual European Academy of Dermatology and Venereology (EADV)...

Read More
DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More thumbnail
Play Button

DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More

Series: DermWire TV | October 10, 2019

In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses her experience. Sandy Klein, co-trustee of the Lynn Waxman Foundation, is this year’s Skin Cancer Foundation Champions for Change Honoree. The Hacking Dermatology 2019 Hackathon puts innovation front and center.

Watch Video

News | October 4, 2019

La Roche-Posay Foundation Opens Call for Abstracts

The La Roche-Posay North American Foundation has opened a call for scientific abstracts.  The La Roche-Posay North American Foundation was established in 2005 to support outstanding candidates with promising projects in the field of...

Read More
Atopic Dermatitis: The Critical Need for Treatment thumbnail
Play Button

Atopic Dermatitis: The Critical Need for Treatment

Series: Eczema Awareness 2019 | September 25, 2019

The therapeutic landscape for atopic dermatitis is expanding, as is understanding of the disease and its impact. More than ever, patients need access to effective therapies and meaningful symptom control strategies, says Adam J. Friedman, MD.

Watch Video
Atopic Dermatitis: Understanding the Impact thumbnail
Play Button

Atopic Dermatitis: Understanding the Impact

Series: Eczema Awareness 2019 | September 25, 2019

For most AD patients, eczema is a bumpy ride. Even mild cases of atopic dermatitis can have a significant effect on people—and these effects range from quality of life impact to treatment costs. Peter Lio, MD describes his approach to a long-term eczema management plan.

Watch Video

Advertisement

The Latest in Eczema

Advertisement

VIDEO | July 30, 2019

Food and Atopic Dermatitis

Meeting Coverage | 2019 AAD Summer Meeting

New York, NY: July 25 - 28, 2019

Peter A. Lio, MD

VIDEO | July 29, 2019

Emerging Therapies for AD

Meeting Coverage | 2019 AAD Summer Meeting

New York, NY: July 25 - 28, 2019

Emma Guttman-Yassky MD, PhD

View more